NCT05478265View on ClinicalTrials.gov

Patient Observational Pain and Activity Survey (POPAS) Study Using RS-4i Sequential Stimulator With Intersperse Technology in Axial Spine and Peripheral Joint Pain

CompletedOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Osteoarthritis
Interventions
DEVICE

RS-4i Plus

RS-4i Plus in an FDA-regulated prescription TENS medical device that outputs and INF signal and a NMES signal and Intersperse signal, which combines INF and NMES into a single treatment.

Trial Locations (1)

92868

University of California at Irvine Medical Center, Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER